The Pharmaceutical Journal
Vol 276 No 7387 p159
11 February 2006

This article
Reprint   Photocopy

  Acrobat Reader

News summary

New antifungal launched

A new broad spectrum antifungal has been launched by Schering Plough.

Posaconazole (Noxafil) is licensed for the treatment of serious refractory invasive fungal infections in patients intolerant to certain other treatments, or in whom they have failed.


Notice-board p163